Cargando…
A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
OBJECTIVE: To screen genes associated with poor prognosis of clear cell renal cell carcinoma (CcRCC) from the public databases HPA (Human Protein Atlas), UALCAN, and GEPIA (Gene Expression Profiling Interactive Analysis) and to investigate the expression of FKBP10 in CcRCC and the effect on prognosi...
Autores principales: | Xiao, Yongshuang, Li, Shuofeng, Zhang, Meng, Liu, Xin, Ju, Guanqun, Hou, Jianquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205734/ https://www.ncbi.nlm.nih.gov/pubmed/35722147 http://dx.doi.org/10.1155/2022/5490644 |
Ejemplares similares
-
Retracted: A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10
por: Ma, Wenliang, et al.
Publicado: (2022) -
ASNS can predict the poor prognosis of clear cell renal cell carcinoma
por: Gan, Xinqiang, et al.
Publicado: (2022) -
Overexpression of NEK2 is correlated with poor prognosis in human clear cell renal cell carcinoma
por: Wang, Chenfeng, et al.
Publicado: (2021) -
High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma
por: Meng, Li, et al.
Publicado: (2017)